Varsity Team Rally 2018 will focus on Advancements in Precision Medicine Research--using biomarkers to individualize cancer prevention and personalize treatment.

Biomarkers help predict what is unique about the individual--what puts them at a greater or lesser risk of cancer and what influences a body's ability to respond to treatment. These biomarkers, found in human tissue, blood and body fluids, may allow researchers to predict--and alter--the course of cancer in patients.

 The use of biomarkers is a common thread connecting precision-medicine-focused research across the Masonic Cancer Center, from identifying environmental carcinogens and exposures, to developing genetic testing which more precisely assesses cancer risk, to using the patient's own immune system to target cancer.

 Through immunotherapy, chemoprevention, and clinical trials, Masonic Cancer Center, University of Minnesota is redefining ways to   diagnose, treat, and prevent cancer--making the most promising cancer treatments available to all Minnesotans -- close to home.

Expert Panel from the Masonic Cancer Center:

Anja Bielinsky, PhD - MCC Assoc Director for Basic Shared Resources; Assoc Dean, Foundational Science; Professor of Biochemistry, Molecular Biology, and Biophysics

Sharon Murphy, PhD - Professor of Biochemistry, Molecular Biology, and Biophysics

Heather Nelson, PhD, MPH - MCC Program Co-Leader for Screening, Prevention, Etiology and Cancer Survivorship; Assoc Professor, Division of Epidemiology and Community Health

Jakub Tolar, MD, PhD - Dean, U of MN Medical School; Distinguished McKnight Professor, Dept of Pediatrics; Edmund Wallace Tulloch and Anna Marie Tulloch Chair in Stem Cell Biology, Genetics, and Genomics

Boris Winterhoff, MD, MS - Asst Professor, Dept of OBGYN

Douglas Yee, MD- MCC Director; Professor of Medicine and Pharmacology; John H Kersey Chair in Cancer Research

Make a free website with Yola